Travis Alvin Thompson
CFO at Bicycle Therapeutics PLC (BCYC); Chief Accounting Officer at Bicycle Therapeutics PLC (BCYC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $31K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 89364,528 held (−1%) | $3.47 | $3K | +12.1% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 7964,449 held (−0%) | $3.57 | $282 | +9.0% |
| Jul 7SEC | BCYCBicycle Therapeutics PLC | Sell | 81964,545 held (−1%) | $4.27 | $3K | -8.9% |
| Jul 7SEC | BCYCBicycle Therapeutics PLC | Sell | 10464,441 held (−0%) | $4.31 | $448 | -9.7% |
| Apr 6SEC | BCYCBicycle Therapeutics PLC | Sell | 79965,466 held (−1%) | $4.91 | $4K | -20.8% |
| Apr 6SEC | BCYCBicycle Therapeutics PLC | Sell | 10265,364 held (−0%) | $5.05 | $515 | -23.0% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell | 1,31767,380 held (−2%) | $6.80 | $9K | -42.8% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell | 1,11566,265 held (−2%) | $6.45 | $7K | -39.7% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 22131,300 held (−1%) | $8.40 | $2K | -53.7% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 10331,197 held (−0%) | $8.41 | $866 | -53.7% |